XML 40 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 10 - SHARE-BASED COMPENSATION
9 Months Ended
Sep. 30, 2013
Share-based Compensation [Abstract]  
NOTE 10 - SHARE-BASED COMPENSATION

For share-based awards granted, we have recognized compensation expense based on the estimated grant date fair value method.  For these awards we have recognized compensation expense using a straight-line amortization method and reduced for estimated forfeitures.  

 

The impact on our results of operations of recording share-based compensation, net of forfeitures, for the three months and nine months ended September 30, 2013 and 2012, respectively, was as follows:

 

    Three Months Ended   Nine Months Ended
    Sep 30,
2013
  Sep 30,
2012
  Sep 30,
2013
  Sep 30,
2012
(in thousands)                
Cost of goods sold   $11   $11   $35   $38
Research and development   15   28   63   88
Selling, general and administrative   76   84   210   279
Total share-based compensation   $102   $123   $308   $405
                 
Impact on net earnings per share:                
Basic and diluted   ($0.01)   ($0.02)   ($0.04)   ($0.05)

 

The fair value of share-based awards for employee stock options was estimated using the Black-Scholes valuation model.  The following weighted average assumptions were used to calculate the fair value of stock options granted during the three months and nine months ended September 30, 2013 and 2012:

 

    Three Months Ended   Nine Months Ended
    Sep 30,
2013
  Sep 30,
2012
  Sep 30,
2013
  Sep 30,
2012
                 
Risk-free interest rates   1.01%   N/A   0.92%   0.62%
Volatility factors   0.54   N/A   0.54   0.53
Expected life of the option in years   4.00   N/A   4.00   4.00
Expected dividend yield   None   N/A   None   None

 

Stock option grants during the three months and nine months ended September 30, 2013 and 2012 were as follows:

    Three Months Ended   Nine Months Ended
    Sep 30,
2013
  Sep 30,
2012
  Sep 30,
2013
  Sep 30,
2012
                 
Stock Options Granted   100,000   -   133,000   190,000

 

  

The remaining unamortized expected future compensation expense and remaining amortization period associated with unvested option grants and restricted stock awards at September 30, 2013 are:

    September 30,
2013
Unamortized future compensation expense   $1,050,535
Remaining weighted average amortization period in years   2.68